We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

73 hedge funds and large institutions have $479M invested in Loxo Oncology, Inc in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 11

117% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 6

9% more funds holding

Funds holding: 6773 (+6)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

5% less capital invested

Capital invested by funds: $504M → $479M (-$24.3M)

Holders
73
Holders Change
+6
Holders Change %
+8.96%
% of All Funds
1.95%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.11%
New
13
Increased
40
Reduced
11
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$2.25M +$1M +40,225 +70%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$2.25M +$662K +26,600 +38%
NIP
28
Nicholas Investment Partners
California
$1.57M +$274K +11,010 +19%
JP Morgan Chase
29
JP Morgan Chase
New York
$1.46M +$1.55M +62,146 +8,692%
USAA
30
United Services Automobile Association
Texas
$1.42M +$275K +11,048 +22%
Ameriprise
31
Ameriprise
Minnesota
$1.38M -$109K -4,359 -7%
BIM
32
BlackRock Investment Management
Delaware
$1.2M +$381K +15,294 +42%
EA
33
Emerald Acquisition
Washington
$918K +$986K +39,612 New
TCIM
34
TIAA CREF Investment Management
New York
$912K +$264K +10,620 +37%
BCM
35
Bridgeway Capital Management
Texas
$701K +$1.25K +50 +0.2%
AA
36
ALPS Advisors
Colorado
$696K +$210K +8,437 +39%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$648K +$209K +8,392 +43%
NFA
38
Nationwide Fund Advisors
Ohio
$542K +$443K +17,775 +316%
TA
39
Teachers Advisors
New York
$492K +$193K +7,741 +57%
Charles Schwab
40
Charles Schwab
California
$478K +$184K +7,400 +56%
Swiss National Bank
41
Swiss National Bank
Switzerland
$468K +$503K +20,200 New
PPA
42
Parametric Portfolio Associates
Washington
$381K +$80.2K +3,222 +24%
SCA
43
Secor Capital Advisors
New York
$340K +$365K +14,640 New
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$335K +$13K +523 +4%
GCP
45
GSA Capital Partners
United Kingdom
$335K +$43.3K +1,740 +14%
AQR Capital Management
46
AQR Capital Management
Connecticut
$331K
Deutsche Bank
47
Deutsche Bank
Germany
$294K +$75.7K +3,042 +31%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$271K -$23.9K -958 -8%
SO
49
STRS Ohio
Ohio
$259K +$22.4K +900 +9%
MLICM
50
Metropolitan Life Insurance Company (MetLife)
New York
$245K +$89.3K +3,588 +51%

LOXO Hedge Fund Activity: Q2 2016 in Review

73 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q2 2016, worth a combined $479M — down 4.8% from $504M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new LOXO positions and 6 closed out — a net gain of 7 holders — while 40 added to existing stakes and 11 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $19.8M. The largest seller was PointState Capital, exiting entirely with an estimated $7.66M sold.

  • 73 institutional investors held Loxo Oncology, Inc (LOXO) as of Q2 2016, up from 67 in Q1 2016.
  • Funds reported $479M of Loxo Oncology, Inc stock for Q2 2016, down 4.8% quarter-over-quarter.
  • 13 funds opened new Loxo Oncology, Inc positions in Q2 2016 and 6 closed out, a net change of +7 holders.
  • The largest Loxo Oncology, Inc buyer in Q2 2016 was Wellington Management Group, an estimated $19.8M added.
  • The largest Loxo Oncology, Inc seller in Q2 2016 was PointState Capital, an estimated $7.66M sold.

Based on aggregated 13F filings for Q2 2016.